Skip to Content

ANI Pharmaceuticals Inc ANIP

Morningstar Rating
$57.63 −0.74 (1.27%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ANIP is trading at a 7% discount.
Price
$58.07
Fair Value
$88.42
Uncertainty
High
1-Star Price
$77.33
5-Star Price
$96.57
Economic Moat
Qdz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ANIP is a good fit for your portfolio.

Trading Information

Previous Close Price
$58.37
Day Range
$57.2958.42
52-Week Range
$36.5465.89
Bid/Ask
$57.68 / $63.89
Market Cap
$1.18 Bil
Volume/Avg
76,114 / 134,560

Key Statistics

Price/Earnings (Normalized)
12.52
Price/Sales
2.18
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
600

Comparables

Valuation

Metric
ANIP
SCLX
016580
Price/Earnings (Normalized)
12.528.23
Price/Book Value
2.660.65
Price/Sales
2.184.791.02
Price/Cash Flow
10.475.77
Price/Earnings
ANIP
SCLX
016580

Financial Strength

Metric
ANIP
SCLX
016580
Quick Ratio
2.770.084.40
Current Ratio
3.700.115.82
Interest Coverage
1.46−71.64990.63
Quick Ratio
ANIP
SCLX
016580

Profitability

Metric
ANIP
SCLX
016580
Return on Assets (Normalized)
9.83%−106.92%7.53%
Return on Equity (Normalized)
22.18%8.40%
Return on Invested Capital (Normalized)
15.23%−569.82%7.50%
Return on Assets
ANIP
SCLX
016580
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AQgpmk$86.3 Bil
MKKGY
Merck KGaA ADRXmlfzh$71.9 Bil
HLN
Haleon PLC ADRHccb$37.8 Bil
VTRS
Viatris IncLff$15.9 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRBjjn$14.7 Bil
RDY
Dr Reddy's Laboratories Ltd ADRFkxvy$12.8 Bil
CTLT
Catalent IncZmrnjs$10.5 Bil
PRGO
Perrigo Co PLCWtwz$4.3 Bil
CURLF
Curaleaf Holdings IncDqnyx$3.7 Bil
PBH
Prestige Consumer Healthcare IncNtdrxgb$3.4 Bil

Sponsor Center